ClinicalTrials.Veeva

Menu

Surgical Outcome of Macular Membrane Peeling Associated With Significant Macular Drusen

K

Klinikum Chemnitz gGmbH

Status

Completed

Conditions

Age Related Macular Degeneration
Macular Holes
Epiretinal Membrane

Treatments

Procedure: pars plana vitrectomy with membrane peeling

Study type

Observational

Funder types

Other

Identifiers

NCT03927430
SKC01/2019

Details and patient eligibility

About

Surgical outcome of patients with macular drusen and co-existing abnormalities of the vitreoretinal interface, who routinely undergo pars plana vitrectomy with membrane peeling, is evaluated. Best corrected visual acuity as well as optical coherence tomography data are compared at baseline and last follow up. The rate of development of choroidal neovascularization postoperatively is noted.

Enrollment

40 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. participants diagnosed with ERM or FTMH and co-existing macular drusen;
  2. undergone pars plana vitrectomy with ILM and epiretinale membrane peeling;
  3. SD-OCT at the initial visit and at last follow up visit with image quality score >30;
  4. no evidence of CNV on initial fluorescein angiography (FA).

Exclusion criteria

  1. history of other macular disease, severe non-proliferative or proliferative diabetic retinopathy, other retinal vascular diseases, glaucoma, myopic retinopathy, or other diseases interfering with OCT images in any one of the eyes;
  2. active CNV or history of CNV

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems